在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human c-myc Oncogene product,c-myc ELISA Kit

  • 中文名稱:
    人c-myc癌基因產物(c-myc)酶聯免疫試劑盒
  • 貨號:
    CSB-E09260h
  • 規格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人c-myc癌基因產物(c-myc)酶聯免疫試劑盒(CSB-E09260h)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿、細胞裂解物樣本中的MYC含量。MYC是重要靶點。它是原癌基因,在細胞增殖、分化及凋亡中起關鍵作用。異常激活與多種癌癥發生發展密切相關。研究聚焦其調控機制,探索抑制途徑,旨在開發針對MYC的抗癌療法,為癌癥治療帶來新可能。試劑盒檢測范圍為0.312 ng/mL-20 ng/mL,該產品適用于腫瘤生物學研究、藥物作用機制探索、細胞周期調控分析等科研場景本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    AU016757 ELISA Kit; Avian myelocytomatosis viral oncogene homolog ELISA Kit; bHLHe39 ELISA Kit; c Myc ELISA Kit; Cellular myelocytomatosis oncogene ELISA Kit; Class E basic helix-loop-helix protein 39 ELISA Kit; MGC105490 ELISA Kit; MRTL ELISA Kit; Myc ELISA Kit; Myc protein ELISA Kit; Myc proto oncogene protein ELISA Kit; Myc proto-oncogene protein ELISA Kit; myc-related translation/localization regulatory factor ELISA Kit; MYC_HUMAN ELISA Kit; Myc2 ELISA Kit; myca ELISA Kit; MYCC ELISA Kit; Myelocytomatosis oncogene a ELISA Kit; Myelocytomatosis oncogene ELISA Kit; Niard ELISA Kit; Nird ELISA Kit; oncogene c-Myc ELISA Kit; Oncogene Myc ELISA Kit; OTTHUMP00000158589 ELISA Kit; OTTHUMP00000227763 ELISA Kit; Proto-oncogene c-Myc ELISA Kit; Protooncogene homologous to myelocytomatosis virus ELISA Kit; RNCMYC ELISA Kit; Transcription factor p64 ELISA Kit; Transcriptional regulator Myc-A ELISA Kit; V-Myc avian myelocytomatosis viral oncogene homolog ELISA Kit; v-myc myelocytomatosis viral oncogene homolog (avian) ELISA Kit; zc-myc ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates, cell lysates
  • 檢測范圍:
    0.312 ng/mL-20 ng/mL
  • 靈敏度:
    0.078 ng/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Epigenetics and Nuclear Signaling
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human c-myc in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
     SampleSerum(n=4)
    1:1Average %93
    Range %87-99
    1:2Average %95
    Range %91-101
    1:4Average %92
    Range %88-96
    1:8Average %90
    Range %86-97
  • 回收率:
    The recovery of human c-myc spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 9085-96
    EDTA plasma (n=4)9287-97
  • 標準曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/mlOD1OD2AverageCorrected
    202.404 2.453 2.429 2.341
    101.587 1.575 1.581 1.493
    51.084 1.066 1.075 0.987
    2.50.658 0.699 0.679 0.591
    1.250.456 0.487 0.472 0.384
    0.6250.251 0.245 0.248 0.160
    0.3120.161 0.169 0.165 0.077
    00.087 0.089 0.088  
  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

相關問答

 常見問題解答
Q:

Do you know if this Human c-myc Oncogene product,c-myc ELISA kit (CSB-E09260h) will be able to detect myc tagged proteins, or only the whole myc protein itself? The myc tag sequence would be EQKLISEEDL.

A:
Thanks for your inquiry.
CSB-E09260h
This kit detects c-myc Oncogene product. It is designed against full length.
Pls refer to: https://www.uniprot.org/uniprot/P01106.
Myc tagged protein you mentioned (https://en.wikipedia.org/wiki/Myc-tag)is a kind of tag protein.
Sorry we didn't do epitope mapping before, so we are not clear if the antibody in the kit can recognize “EQKLISEEDL”or not.

靶點詳情

  • 功能:
    Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Activates the transcription of growth-related genes. Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis. Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells. Functions with TAF6L to activate target gene expression through RNA polymerase II pause release.
  • 基因功能參考文獻:
    1. the findings of this study demonstrate that hsamiR24 suppresses metastasis in nasopharyngeal carcinoma by regulating the cMyc/EMT axis, suggesting that hsamiR24 may be used as a prognostic factor and as a novel target for the prevention of nasopharyngeal carcinoma metastasis. PMID: 30226609
    2. lncRNA THOR is up-regulated in retinoblastoma, and its over-expression significantly enhances the malignant phenotype transformation of retinoblastoma cells by up-regulating c-myc and TGF2BP1 expression. PMID: 30119193
    3. we demonstrate that neither MYC IHC nor MYC FISH alone is a sufficient screening mechanism for identification of the clinically relevant entities of HGBLwR or DEL PMID: 28868942
    4. Because RPL23 is encoded by a target gene of c-Myc, the RPL23/Miz-1/c-Myc regulatory circuit provides a feedback loop that links efficient RPL23 expression with c-Myc's function to suppress Miz-1-induced Cdk inhibitors and thereby leads to apoptotic resistance in higher-risk myelodysplastic syndrome patients. PMID: 28539603
    5. GATAD2B interacts with C-MYC to enhance KRAS driven tumor growth. PMID: 30013058
    6. low expression of c-Myc protein predicts poor outcomes in patients with HCC with hepatectomy. PMID: 29690860
    7. Combined, these findings suggest that c-Myc could transcriptionally regulate TCRP1 in cell lines and clinical samples and identified the c-Myc-TCRP1 axis as a negative biomarker of prognosis in tongue and lung cancers. PMID: 28623290
    8. Kazakh and Han patients with esophageal squamous cell carcinoma with Glut1 c-myc co-expression had poorer prognosis. PMID: 29629851
    9. MYC activation in papillary clear cell renal cell carcinoma leads to a worse prognosis. PMID: 28593993
    10. could not find any relationship between Bcl-2, c-Myc and EBER-ISH positivity and the low/high IPS groups in classical Hodgkin lymphoma PMID: 29708579
    11. Fluorescence in situ hybridization studies (histologic sections) confirmed translocations of MYC (8q24), BCL2 (18q21) and BCL6 (3q27) in all patients. PMID: 30043475
    12. topical mevastatin accelerates wound closure by promoting epithelialization via multiple mechanisms: modulation of GR ligands and induction of the long noncoding RNA Gas5, leading to c-Myc inhibition. PMID: 29158265
    13. CCND1 , C-MYC , and FGFR1 amplifications were observed in 34.28%, 28.57%, and 17.14% of the 35 samples (invasive ductal breast carcinoma). PMID: 30119151
    14. Data suggest that MYC induction of REV-ERBalpha is both persistent and recurrent across many inducible MYC model systems. PMID: 28332504
    15. HUWE1 overexpression could functionally suppress prostate carcinoma development both in vitro and in vivo, possibly by inverse regulation of c-Myc. PMID: 29966975
    16. Menin functions as an oncogenic regulatory factor that is critical for MYC-mediated gene transcription. PMID: 28474697
    17. High c-myc expression is associated with colorectal cancer. PMID: 30015962
    18. Melatonin disturbs SUMOylation-mediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells. PMID: 29654697
    19. FBP1 modulates the sensitivity of pancreatic cancer cells to BET inhibitors by decreasing the expression of c-Myc. These findings highlight FBP1 could be used as a therapeutic niche for patient-tailored therapies PMID: 30201002
    20. miR135a directly bound to UCA1 and the 3' untranslated region of cmyc, and UCA1 competed with cmyc for miR135a binding. PMID: 30015867
    21. MYC directly regulates DANCR and plays important role in cancer cell proliferation. PMID: 29180471
    22. In this review, we provide support to the hypothesis that the cooperation of c-Myc with transcriptional cofactors mediates c-Myc-induced cellular functions. We produce evidence that recently identified cofactors are involved in c-Myc control of survival mechanisms of cancer cells PMID: 30261904
    23. 4-chlorobenzoyl berbamine (CBBM) inhibits the JAK2/STAT3 pathway, leading to reduced c-Myc transcription. Collectively, these findings suggest that CBBM could be a promising lead compound for treatment of c-Myc-driven diffuse large B cell lymphoma. PMID: 30099568
    24. Results revealed that C-MYC protein is highly expressed in colon cancer tissues, mainly in the cell nucleus and was identified as a direct target for mir-184. C-MYC appeared to participate in cell cycle regulation and malignant transformation to colon cancer. PMID: 28782841
    25. MACC1 and c-Myc are highly expressed in serum and tumor tissues of EC patients. Both are correlated with TNM stage, primary infiltration, and lymph node or distal metastasis. PMID: 29984790
    26. study provides an interesting example using chemical biological approaches for determining distinct biological consequences from inhibiting vs. activating an E3 ubiquitin ligase and suggests a potential broad therapeutic strategy for targeting c-MYC in cancer treatment by pharmacologically modulating cIAP1 E3 ligase activity. PMID: 30181285
    27. The data demonstrated that 10058F4, a cMyc inhibitor, increased the growth inhibition, G0/G1 phase arrest and apoptosis of the NALM6 and CEM cells as induced by dexamethasone (DXM), a type of GC. PMID: 29749488
    28. c-MYC/BCL2 protein co-expression is associated with non-germinal center B-cell in Diffuse Large B-Cell Lymphoma PMID: 29801406
    29. c-Myc was capable of upregulating HP1gamma by directly binding to the E-box element in the first intron of HP1gamma gene, and the upregulated HP1gamma, in turn, repressed the expression of miR-451a by enhancing H3K9 methylation at the promoter region of miR-451a. PMID: 28967902
    30. A subset of pancreatic acinar cell carcinomas shows c-MYC alterations including gene amplification and chromosome 8 polysomy. PMID: 29721608
    31. Expression and Clinical Significance of LC-3 and P62 in Non-small Cell Lung Cancer PMID: 29945702
    32. The findings of the current study demonstrate presence of the IDH1 R132H mutation in primary human glioblastoma cell lines with upregulated HIF-1alpha expression, downregulating c-MYC activity and resulting in a consequential decrease in miR-20a, which is responsible for cell proliferation and resistance to standard temozolomide treatment. PMID: 29625108
    33. a novel signal circuit of Stat3/Oct-4/c-Myc was identified for regulating stemness-mediated Doxorubicin resistance in triple-negative breast cancer PMID: 29750424
    34. MYC amplification and MYC overexpression occurred almost exclusively in secondary cutaneous angiosarcoma in our series. PMID: 29135507
    35. High c-myc expression is associated with the development of prostate cancer. PMID: 29554906
    36. Circular RNA hsa_circRNA_103809 promotes lung cancer progression via facilitating ZNF121-dependent MYC expression by sequestering miR-4302. PMID: 29698681
    37. Authors conclude that quantitative measurements of intratumor heterogeneity by multiplex FISH, detection of MYC amplification and TP53 mutation could augment prognostication in breast cancer patients. PMID: 29181861
    38. PCYT1A was upregulated by MYC, which resulted in the induction of aberrant choline metabolism and the inhibition of B-lymphoma cell necroptosis. PMID: 28686226
    39. Cryptic t(3;8)(q27;q24) and/or MYC-BCL6 linkage associated with MYC expression by immunohistochemistry is frequent in multiple-hit B-cell lymphomas. PMID: 28665415
    40. CD30+ diffuse large B-cell lymphoma has characteristic clinicopathological features mutually exclusive with MYC gene rearrangement and negatively associated with BCL2 protein expression. PMID: 29666157
    41. High MYC amplification is associated with HER2 positive breast cancers in African American women. PMID: 29523126
    42. These data suggest that MYC acts as a master coordinator that inversely modulates the impact of cell cycle and circadian clock on gene expression via its interaction with MIZ1. PMID: 27339797
    43. In our study, the c-myc oncogene was amplified in 11.1% of BPH samples. Bivariate analysis failed to reveal any significant association between oncogene amplification and the clinicopathologic variables examined. PMID: 29234244
    44. Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF1A and HIF1B binding to a MYC enhancer. PMID: 27774982
    45. Data indicate that miR-34a enhanced the sensitivity to cisplatin by upregulation of c-Myc and Bim pathway. PMID: 29060932
    46. Luciferase reporter assay showed that c-Myc, an oncogene that regulating cell survival, angiogenesis and metastasis, was a direct target of miR-376a. Over-expression of miR-376a decreased the mRNA and protein levels of c-Myc in A549 cells. PMID: 28741879
    47. The present findings show that expression of c-MYC has prognostic value in squamous cell carcinoma of the tongue, and could be useful in choice of therapy. PMID: 28393404
    48. Multivariable analysis indicated that IPI (P = 0.002), chemotherapy regimens (P = 0.017), and MYC gene rearrangements (P = 0.004) were independent adverse prognostic factors for all diffuse large B cell Lymphoma(DLBCL) patients in this study. Results demonstrated that the poor survival of DLBCL patients with HBV infection was closely involved in chemotherapy regimens, IPI, and MYC gene rearrangements PMID: 29209623
    49. MYC extra copy in diffuse large B-cell lymphoma is an independent poor prognostic factor PMID: 28776574
    50. The c-Myc/miR-200b/PRDX2 loop regulates colorectal cancer (CRC) progression and its disruption enhances tumor metastasis and chemotherapeutic resistance in CRC. PMID: 29258530

    顯示更多

    收起更多

  • 相關疾病:
    Burkitt lymphoma (BL)
  • 亞細胞定位:
    Nucleus, nucleoplasm. Nucleus, nucleolus.
  • 數據庫鏈接:

    HGNC: 7553

    OMIM: 113970

    KEGG: hsa:4609

    STRING: 9606.ENSP00000367207

    UniGene: Hs.202453



主站蜘蛛池模板: 忘忧草社区在线资源www| 亚洲中文字幕无码久久2018| 国产乱女乱子视频在线播放| 巨人精品福利官方导航| 香蕉视频在线观看亚洲| 99精品国产99久久久久久97| 中文字幕人妻无码专区| 国产香蕉国产精品偷在线| 国产精品人成在线播放新网站| 人人爽天天碰狠狠添| 欧美又黄又大又爽a片三年片| 内射合集对白在线| 国产真实乱人偷精品人妻| 亚洲精品久久久久久下一站| 最新色国产精品精品视频| 国产午夜a理论毛片| 成人无码a∨电影免费| 欧美男男大粗吊1069| 日本乱人伦在线观看| 精品无人区一区二区三区| 亚洲国产成人爱av在线播放| 一区二区视频日韩免费| 午夜无码国产理论在线| 色插图午夜影院| 秋霞国产午夜伦午夜福利片| 色婷婷国产精品高潮呻吟av久久 | av影音先锋最大资源网| 欧洲国产伦久久久久久久| 激情综合婷婷丁香五月蜜桃| 亚洲精品乱码久久久久久中文字幕| 国产精品55夜色66夜色| 日韩人妻无码精品-专区| 俺去俺来也在线www色官网| 欧洲多毛裸体xxxxx| 天堂在线www中文| 蜜臀少妇人妻在线| 性做久久久久久久免费看| 国产麻豆精品一区| 国产又色又爽又黄的在线观看视频| 老司机性色福利精品视频| 国产亚洲综合区成人国产系列 |